Last Updated : November 8, 2024
Details
FilesProject Status:
Active
Therapeutic Area:
Non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0054-000
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | 31-Oct-2024 |
| Stakeholder Feedback Deadline: | 7-Nov-2024 |
| Final Report Posted (Target): | 4-Dec-2024 |
Files
Last Updated : November 8, 2024